EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
+8.69%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$780M
AUM Growth
+$780M
(-12%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-21.4%
Top 10 Holdings %
Top 10 Hldgs %
99.62%
Holding
13
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$30.1M |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$197M |
Sector Composition
| 1 | Healthcare | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P 500 ETF Trust
SPY
$658B
| $510M | 65.36% |
974,641
+57,500
| +6% | +$30.1M |
|
2
iShares MSCI India ETF
INDA
$9.17B
| $125M | 16.04% |
2,425,144
| – | – |
|
|
3
SPDR Gold Trust
GLD
$107B
| $88.9M | 11.4% |
432,271
-957,729
| -69% | -$197M |
|
4
Oric Pharmaceuticals
ORIC
$994M
| $13.6M | 1.74% |
989,410
| – | – |
|
5
Foghorn Therapeutics
FHTX
$286M
| $10.6M | 1.35% |
1,573,761
| – | – |
|
6
Alector
ALEC
$238M
| $7.87M | 1.01% |
1,307,858
| – | – |
|
7
RAPT Therapeutics
RAPT
$188M
| $5.91M | 0.76% |
657,899
| – | – |
|
|
ME
8
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $5.45M | 0.7% |
10,243,122
| – | – |
|
9
Tenaya Therapeutics
TNYA
$184M
| $5.31M | 0.68% |
1,015,705
| – | – |
|
10
PMV Pharmaceuticals
PMVP
$74.2M
| $4.47M | 0.57% |
2,627,643
| – | – |
|
|
NGM
11
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.58M | 0.2% |
992,168
| – | – |
|
12
Surrozen
SRZN
$104M
| $1.38M | 0.18% |
87,696
| – | – |
|
|
13
Surrozen, Inc. Warrant
SRZNW
$71.6K
| $5.16K | ﹤0.01% |
170,833
| – | – |
|